Prolonged Inotrope Use After Surgery for Congenital Heart Disease: A Common Occurrence with a High Burden of Mortality

Outcomes in patients requiring prolonged inotropes (PI) following surgery for congenital heart disease (CHD) have not been well studied. We aimed to describe the burden of PI use in the immediate postoperative period after CHD surgery and identify risk factors for in-hospital mortality. We conducted...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pediatric cardiology 2024-08
Hauptverfasser: Kamsheh, Alicia M, Bilker, Warren B, Huang, Yuan-Shung, Okunowo, Oluwatimilehin, Burstein, Danielle S, Edelson, Jonathan B, Lin, Kimberly Y, Maeda, Katsuhide, Mavroudis, Constantine D, O'Connor, Matthew J, Wittlieb-Weber, Carol A, Bogner, Hillary R, Rossano, Joseph W
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title Pediatric cardiology
container_volume
creator Kamsheh, Alicia M
Bilker, Warren B
Huang, Yuan-Shung
Okunowo, Oluwatimilehin
Burstein, Danielle S
Edelson, Jonathan B
Lin, Kimberly Y
Maeda, Katsuhide
Mavroudis, Constantine D
O'Connor, Matthew J
Wittlieb-Weber, Carol A
Bogner, Hillary R
Rossano, Joseph W
description Outcomes in patients requiring prolonged inotropes (PI) following surgery for congenital heart disease (CHD) have not been well studied. We aimed to describe the burden of PI use in the immediate postoperative period after CHD surgery and identify risk factors for in-hospital mortality. We conducted a retrospective cohort study using the Pediatric Health Information System® (PHIS) database. Patients 0-18 years with CHD who underwent cardiovascular surgery from 2010 to 2020 were included. Patients who received inotropic medications for > 7 consecutive days after surgery were in the PI group and all others in the control group. Patients who died before 7 days were excluded. Multivariable mixed-effect logistic regression was used to examine risk factors for in-hospital mortality. There were 110,271 patients from 48 centers included, 10,292 in the PI group and 99,979 in the control group. In-hospital mortality was significantly higher in the PI group (24.9% vs. 4.6%, p 
doi_str_mv 10.1007/s00246-024-03619-1
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_3092871949</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3092871949</sourcerecordid><originalsourceid>FETCH-LOGICAL-p141t-e382c36c482ecd4e8bf8895af6d4f242055653e88994b19caec69bf0b1d6246d3</originalsourceid><addsrcrecordid>eNpNkMtOwzAQRS0EolD4ARbISzYBv5La7Ep5tFJRkaDryHHGbVASB9sB9e8Jokhs5o5mzlyNLkIXlFxTQiY3gRAmsmQoCeEZVQk9QCdUcJZQNaGH__oROg3hnRAiiUyP0YgrKihl6Qn6fPGudu0GSrxoXfSuA7wOgKc2gsevvd-A32HrPJ79UG0VdY3noH3E91UAHeAWT4dd07gWr4zpvYfWAP6q4hZrPK82W3zX-xJa7Cx-dn64r-LuDB1ZXQc43-sYrR8f3mbzZLl6Wsymy6QbHowJcMkMz4yQDEwpQBZWSpVqm5XCMsFImmYph2GmREGV0WAyVVhS0DIboin5GF39-nbeffQQYt5UwUBd6xZcH3JOFJMTqoQa0Ms92hcNlHnnq0b7Xf6XFf8G6_tsDQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3092871949</pqid></control><display><type>article</type><title>Prolonged Inotrope Use After Surgery for Congenital Heart Disease: A Common Occurrence with a High Burden of Mortality</title><source>SpringerNature Journals</source><creator>Kamsheh, Alicia M ; Bilker, Warren B ; Huang, Yuan-Shung ; Okunowo, Oluwatimilehin ; Burstein, Danielle S ; Edelson, Jonathan B ; Lin, Kimberly Y ; Maeda, Katsuhide ; Mavroudis, Constantine D ; O'Connor, Matthew J ; Wittlieb-Weber, Carol A ; Bogner, Hillary R ; Rossano, Joseph W</creator><creatorcontrib>Kamsheh, Alicia M ; Bilker, Warren B ; Huang, Yuan-Shung ; Okunowo, Oluwatimilehin ; Burstein, Danielle S ; Edelson, Jonathan B ; Lin, Kimberly Y ; Maeda, Katsuhide ; Mavroudis, Constantine D ; O'Connor, Matthew J ; Wittlieb-Weber, Carol A ; Bogner, Hillary R ; Rossano, Joseph W</creatorcontrib><description>Outcomes in patients requiring prolonged inotropes (PI) following surgery for congenital heart disease (CHD) have not been well studied. We aimed to describe the burden of PI use in the immediate postoperative period after CHD surgery and identify risk factors for in-hospital mortality. We conducted a retrospective cohort study using the Pediatric Health Information System® (PHIS) database. Patients 0-18 years with CHD who underwent cardiovascular surgery from 2010 to 2020 were included. Patients who received inotropic medications for &gt; 7 consecutive days after surgery were in the PI group and all others in the control group. Patients who died before 7 days were excluded. Multivariable mixed-effect logistic regression was used to examine risk factors for in-hospital mortality. There were 110,271 patients from 48 centers included, 10,292 in the PI group and 99,979 in the control group. In-hospital mortality was significantly higher in the PI group (24.9% vs. 4.6%, p &lt; 0.001). Ventricular assist device use was rare (1.6%). After adjustment, odds of in-hospital mortality in the PI group was 3.5 (95% CI 3.3-3.8) times higher than in controls. Independent risk factors for in-hospital mortality were age, non-White race, class of CHD, number of complex chronic conditions, preoperative inotrope, preoperative extracorporeal membrane oxygenation, sepsis, stroke, renal failure, number of inotropes at 7 days, and discharge year (p &lt; 0.01 for all). Postoperative PI use in CHD is common and carries a considerable burden of mortality. Additional work is needed to understand which risk factors are modifiable and which patients may benefit from reintervention or advanced heart failure therapies.</description><identifier>ISSN: 1432-1971</identifier><identifier>EISSN: 1432-1971</identifier><identifier>DOI: 10.1007/s00246-024-03619-1</identifier><identifier>PMID: 39141125</identifier><language>eng</language><publisher>United States</publisher><ispartof>Pediatric cardiology, 2024-08</ispartof><rights>2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0003-3012-5464 ; 0000-0002-8284-0673 ; 0000-0002-1942-6197 ; 0000-0003-3220-7922 ; 0000-0001-7941-5599 ; 0000-0003-1582-9797 ; 0000-0001-5145-7121 ; 0000-0001-8841-4926</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39141125$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kamsheh, Alicia M</creatorcontrib><creatorcontrib>Bilker, Warren B</creatorcontrib><creatorcontrib>Huang, Yuan-Shung</creatorcontrib><creatorcontrib>Okunowo, Oluwatimilehin</creatorcontrib><creatorcontrib>Burstein, Danielle S</creatorcontrib><creatorcontrib>Edelson, Jonathan B</creatorcontrib><creatorcontrib>Lin, Kimberly Y</creatorcontrib><creatorcontrib>Maeda, Katsuhide</creatorcontrib><creatorcontrib>Mavroudis, Constantine D</creatorcontrib><creatorcontrib>O'Connor, Matthew J</creatorcontrib><creatorcontrib>Wittlieb-Weber, Carol A</creatorcontrib><creatorcontrib>Bogner, Hillary R</creatorcontrib><creatorcontrib>Rossano, Joseph W</creatorcontrib><title>Prolonged Inotrope Use After Surgery for Congenital Heart Disease: A Common Occurrence with a High Burden of Mortality</title><title>Pediatric cardiology</title><addtitle>Pediatr Cardiol</addtitle><description>Outcomes in patients requiring prolonged inotropes (PI) following surgery for congenital heart disease (CHD) have not been well studied. We aimed to describe the burden of PI use in the immediate postoperative period after CHD surgery and identify risk factors for in-hospital mortality. We conducted a retrospective cohort study using the Pediatric Health Information System® (PHIS) database. Patients 0-18 years with CHD who underwent cardiovascular surgery from 2010 to 2020 were included. Patients who received inotropic medications for &gt; 7 consecutive days after surgery were in the PI group and all others in the control group. Patients who died before 7 days were excluded. Multivariable mixed-effect logistic regression was used to examine risk factors for in-hospital mortality. There were 110,271 patients from 48 centers included, 10,292 in the PI group and 99,979 in the control group. In-hospital mortality was significantly higher in the PI group (24.9% vs. 4.6%, p &lt; 0.001). Ventricular assist device use was rare (1.6%). After adjustment, odds of in-hospital mortality in the PI group was 3.5 (95% CI 3.3-3.8) times higher than in controls. Independent risk factors for in-hospital mortality were age, non-White race, class of CHD, number of complex chronic conditions, preoperative inotrope, preoperative extracorporeal membrane oxygenation, sepsis, stroke, renal failure, number of inotropes at 7 days, and discharge year (p &lt; 0.01 for all). Postoperative PI use in CHD is common and carries a considerable burden of mortality. Additional work is needed to understand which risk factors are modifiable and which patients may benefit from reintervention or advanced heart failure therapies.</description><issn>1432-1971</issn><issn>1432-1971</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNpNkMtOwzAQRS0EolD4ARbISzYBv5La7Ep5tFJRkaDryHHGbVASB9sB9e8Jokhs5o5mzlyNLkIXlFxTQiY3gRAmsmQoCeEZVQk9QCdUcJZQNaGH__oROg3hnRAiiUyP0YgrKihl6Qn6fPGudu0GSrxoXfSuA7wOgKc2gsevvd-A32HrPJ79UG0VdY3noH3E91UAHeAWT4dd07gWr4zpvYfWAP6q4hZrPK82W3zX-xJa7Cx-dn64r-LuDB1ZXQc43-sYrR8f3mbzZLl6Wsymy6QbHowJcMkMz4yQDEwpQBZWSpVqm5XCMsFImmYph2GmREGV0WAyVVhS0DIboin5GF39-nbeffQQYt5UwUBd6xZcH3JOFJMTqoQa0Ms92hcNlHnnq0b7Xf6XFf8G6_tsDQ</recordid><startdate>20240814</startdate><enddate>20240814</enddate><creator>Kamsheh, Alicia M</creator><creator>Bilker, Warren B</creator><creator>Huang, Yuan-Shung</creator><creator>Okunowo, Oluwatimilehin</creator><creator>Burstein, Danielle S</creator><creator>Edelson, Jonathan B</creator><creator>Lin, Kimberly Y</creator><creator>Maeda, Katsuhide</creator><creator>Mavroudis, Constantine D</creator><creator>O'Connor, Matthew J</creator><creator>Wittlieb-Weber, Carol A</creator><creator>Bogner, Hillary R</creator><creator>Rossano, Joseph W</creator><scope>NPM</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3012-5464</orcidid><orcidid>https://orcid.org/0000-0002-8284-0673</orcidid><orcidid>https://orcid.org/0000-0002-1942-6197</orcidid><orcidid>https://orcid.org/0000-0003-3220-7922</orcidid><orcidid>https://orcid.org/0000-0001-7941-5599</orcidid><orcidid>https://orcid.org/0000-0003-1582-9797</orcidid><orcidid>https://orcid.org/0000-0001-5145-7121</orcidid><orcidid>https://orcid.org/0000-0001-8841-4926</orcidid></search><sort><creationdate>20240814</creationdate><title>Prolonged Inotrope Use After Surgery for Congenital Heart Disease: A Common Occurrence with a High Burden of Mortality</title><author>Kamsheh, Alicia M ; Bilker, Warren B ; Huang, Yuan-Shung ; Okunowo, Oluwatimilehin ; Burstein, Danielle S ; Edelson, Jonathan B ; Lin, Kimberly Y ; Maeda, Katsuhide ; Mavroudis, Constantine D ; O'Connor, Matthew J ; Wittlieb-Weber, Carol A ; Bogner, Hillary R ; Rossano, Joseph W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p141t-e382c36c482ecd4e8bf8895af6d4f242055653e88994b19caec69bf0b1d6246d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kamsheh, Alicia M</creatorcontrib><creatorcontrib>Bilker, Warren B</creatorcontrib><creatorcontrib>Huang, Yuan-Shung</creatorcontrib><creatorcontrib>Okunowo, Oluwatimilehin</creatorcontrib><creatorcontrib>Burstein, Danielle S</creatorcontrib><creatorcontrib>Edelson, Jonathan B</creatorcontrib><creatorcontrib>Lin, Kimberly Y</creatorcontrib><creatorcontrib>Maeda, Katsuhide</creatorcontrib><creatorcontrib>Mavroudis, Constantine D</creatorcontrib><creatorcontrib>O'Connor, Matthew J</creatorcontrib><creatorcontrib>Wittlieb-Weber, Carol A</creatorcontrib><creatorcontrib>Bogner, Hillary R</creatorcontrib><creatorcontrib>Rossano, Joseph W</creatorcontrib><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Pediatric cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kamsheh, Alicia M</au><au>Bilker, Warren B</au><au>Huang, Yuan-Shung</au><au>Okunowo, Oluwatimilehin</au><au>Burstein, Danielle S</au><au>Edelson, Jonathan B</au><au>Lin, Kimberly Y</au><au>Maeda, Katsuhide</au><au>Mavroudis, Constantine D</au><au>O'Connor, Matthew J</au><au>Wittlieb-Weber, Carol A</au><au>Bogner, Hillary R</au><au>Rossano, Joseph W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prolonged Inotrope Use After Surgery for Congenital Heart Disease: A Common Occurrence with a High Burden of Mortality</atitle><jtitle>Pediatric cardiology</jtitle><addtitle>Pediatr Cardiol</addtitle><date>2024-08-14</date><risdate>2024</risdate><issn>1432-1971</issn><eissn>1432-1971</eissn><abstract>Outcomes in patients requiring prolonged inotropes (PI) following surgery for congenital heart disease (CHD) have not been well studied. We aimed to describe the burden of PI use in the immediate postoperative period after CHD surgery and identify risk factors for in-hospital mortality. We conducted a retrospective cohort study using the Pediatric Health Information System® (PHIS) database. Patients 0-18 years with CHD who underwent cardiovascular surgery from 2010 to 2020 were included. Patients who received inotropic medications for &gt; 7 consecutive days after surgery were in the PI group and all others in the control group. Patients who died before 7 days were excluded. Multivariable mixed-effect logistic regression was used to examine risk factors for in-hospital mortality. There were 110,271 patients from 48 centers included, 10,292 in the PI group and 99,979 in the control group. In-hospital mortality was significantly higher in the PI group (24.9% vs. 4.6%, p &lt; 0.001). Ventricular assist device use was rare (1.6%). After adjustment, odds of in-hospital mortality in the PI group was 3.5 (95% CI 3.3-3.8) times higher than in controls. Independent risk factors for in-hospital mortality were age, non-White race, class of CHD, number of complex chronic conditions, preoperative inotrope, preoperative extracorporeal membrane oxygenation, sepsis, stroke, renal failure, number of inotropes at 7 days, and discharge year (p &lt; 0.01 for all). Postoperative PI use in CHD is common and carries a considerable burden of mortality. Additional work is needed to understand which risk factors are modifiable and which patients may benefit from reintervention or advanced heart failure therapies.</abstract><cop>United States</cop><pmid>39141125</pmid><doi>10.1007/s00246-024-03619-1</doi><orcidid>https://orcid.org/0000-0003-3012-5464</orcidid><orcidid>https://orcid.org/0000-0002-8284-0673</orcidid><orcidid>https://orcid.org/0000-0002-1942-6197</orcidid><orcidid>https://orcid.org/0000-0003-3220-7922</orcidid><orcidid>https://orcid.org/0000-0001-7941-5599</orcidid><orcidid>https://orcid.org/0000-0003-1582-9797</orcidid><orcidid>https://orcid.org/0000-0001-5145-7121</orcidid><orcidid>https://orcid.org/0000-0001-8841-4926</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1432-1971
ispartof Pediatric cardiology, 2024-08
issn 1432-1971
1432-1971
language eng
recordid cdi_proquest_miscellaneous_3092871949
source SpringerNature Journals
title Prolonged Inotrope Use After Surgery for Congenital Heart Disease: A Common Occurrence with a High Burden of Mortality
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T06%3A52%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prolonged%20Inotrope%20Use%20After%20Surgery%20for%20Congenital%20Heart%20Disease:%20A%20Common%20Occurrence%20with%20a%20High%20Burden%20of%20Mortality&rft.jtitle=Pediatric%20cardiology&rft.au=Kamsheh,%20Alicia%20M&rft.date=2024-08-14&rft.issn=1432-1971&rft.eissn=1432-1971&rft_id=info:doi/10.1007/s00246-024-03619-1&rft_dat=%3Cproquest_pubme%3E3092871949%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3092871949&rft_id=info:pmid/39141125&rfr_iscdi=true